tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market

Zentalis Pharmaceuticals (ZNTL) Balance Sheet

221 Followers

Zentalis Pharmaceuticals Balance Sheet

Zentalis Pharmaceuticals's total assets for Q4 2023 were $551.69M, a decrease of -5.81% from the previous quarter. ZNTL total liabilities were $114.30M for the fiscal quarter, a 10.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 551.69M$ 539.31M$ 454.51M$ 365.56M$ 87.48M
Total Liabilities
$ 114.30M$ 105.29M$ 90.03M$ 32.18M$ 160.77M
Total Equity Gross Minority
$ 437.39M$ 434.02M$ 364.48M$ 333.38M$ -73.28M
Total Capitalization
$ 480.43M$ 478.97M$ 363.95M$ 308.58M$ -80.11M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 2.00M$ 781.00K
Currency in USD

Zentalis Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis